News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Western Midstream yields ~9.2% and trades at a mid‑teens P/E.
  • A trade idea positions for a potential WES re‑rating by 2027 with explicit entry, stop, and target levels.
  • Technical indicators show WES is oversold and analysts are raising estimates.
  • Credo Technology was upgraded to Buy after a pullback based on high‑speed interconnect market position.
  • Credo's upgrade cites recent optical product push and positive free cash flow supporting upside.
  • Analysts warn Credo faces concentrated customers and premium multiples, making execution on bookings and margins critical.

Latest Articles

Bitcoin: Ignore the Clarity Act Noise and Trade the 200-Week Pivot

Bitcoin: Ignore the Clarity Act Noise and Trade the 200-Week Pivot

Markets are obsessing over the Clarity Act narrative again, but the more actionable input for traders is a classic chart: Bitcoin's interaction with the 200-week moving average and the realized-price band. This trade idea lays out a clear, quantified entry, stop and target around that technical/on-chain pivot, with a 180-trading-day horizon and exp…

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Cytokinetics announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for MYQORZO® (aficamten), a cardiac myosin inhibitor, to treat symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults. Concurrently, the National Institute for Health and Care Excellence (NICE) issued posit…

Haleon Shares Slip After H1 Results Show Growth Short of Targets

Haleon Shares Slip After H1 Results Show Growth Short of Targets

Haleon stock fell after the company reported H1 2026 results showing organic revenue growth of 2.6% for the half, driven by 2.1% pricing and 0.5% volume and mix. Despite Q2 acceleration to 3.1% from 2.2% in Q1, results remained below the firm’s medium-term annual 4-6% target and H1 revenue of about £5.55 billion missed analyst expectations near £5.…

Core Scientific Shares Rebound After Analyst Upgrades, AMD Colocation Deal

Core Scientific Shares Rebound After Analyst Upgrades, AMD Colocation Deal

Core Scientific gained in pre-market trading after steep losses the previous session, buoyed by a string of analyst price-target increases tied to a large AI infrastructure lease with AMD, a stronger-than-expected top-line result, and a board appointment signaling a shift toward high-density AI colocation. Offsetting factors include a second-quarte…

Brunswick Corporation Releases 2026 Second Quarter Earnings

Brunswick Corporation Releases 2026 Second Quarter Earnings

Brunswick Corporation released its financial results for the second quarter of 2026, providing investors with access to a full-text press release, webcast, and conference call details. The company emphasized its global market presence in marine recreation products and its broad brand portfolio. Forward-looking statements caution about various econo…

Why Americans Are Leasing Fewer Cars as Automakers Scale Back Low-Rate Deals

Why Americans Are Leasing Fewer Cars as Automakers Scale Back Low-Rate Deals

U.S. vehicle leasing has not returned to pre-pandemic levels after falling sharply during post-pandemic shortages. Automakers' reduced willingness to offer low monthly lease payments, combined with higher interest rates and tighter inventories, has pushed some buyers into extended financing and constrained the supply of off-lease used vehicles.

ServiceNow: User Retention Is Picking Up — Time to Add Exposure

ServiceNow: User Retention Is Picking Up — Time to Add Exposure

ServiceNow's workflow platform is showing accelerating user retention and steady revenue momentum. The business generates strong free cash flow, has minimal leverage, and technical momentum is improving. Valuation is premium, but a disciplined long with a clear stop and target provides asymmetric upside if retention and AI-driven monetization conti…

Buy Phillips 66 Now: Tactical, High-Conviction Entry Ahead of Earnings

Buy Phillips 66 Now: Tactical, High-Conviction Entry Ahead of Earnings

Phillips 66 (PSX) presents a structured, mid-term long trade ahead of earnings. Strong crack spreads and higher refining utilization have re-rated the stock, while a $2.0-2.5B capex push into midstream capacity should underpin longer-term cash flow. Valuation is reasonable on P/E (~20) and EV/EBITDA (~15), but stretched on P/FCF, so risk management…

Democratic Senators Press Treasury to Restore Harriet Tubman $20 Redesign

Democratic Senators Press Treasury to Restore Harriet Tubman $20 Redesign

A group of U.S. Democratic senators has urged Treasury Secretary Scott Bessent to reinstate plans to place Harriet Tubman on the $20 note after the Treasury indicated it was no longer pursuing the redesign. The request follows an Obama-era announcement that Tubman would replace Andrew Jackson, and comes amid separate discussions within the administ…

High Rate of Dropped Federal Assault Cases Leaves Defendants Facing Lasting Harm

High Rate of Dropped Federal Assault Cases Leaves Defendants Facing Lasting Harm

A review of federal court records shows that the Trump administration pursued criminal charges against at least 851 people accused of assaulting or impeding federal officers, and that an unusually large share of those prosecutions were later dropped. The practice has produced substantial collateral consequences for defendants — lost jobs, seized pr…

KBR Reports Second Quarter Fiscal 2026 Results

KBR Reports Second Quarter Fiscal 2026 Results

KBR, Inc. reported second quarter fiscal 2026 revenues of $2.0 billion, up 2% year-over-year, with net income attributable to KBR rising 32% to $96 million. Adjusted EBITDA increased 7% to $258 million, supported by strong performance in its Sustainable Technology Solutions segment and healthy demand in Mission Technology Solutions internationally.…

L’Oréal Targets 2028 Debut for Gucci Beauty Line as License Transfer Nears

L’Oréal Targets 2028 Debut for Gucci Beauty Line as License Transfer Nears

L’Oréal intends to begin selling Gucci-branded beauty products as early as 2028 after taking over the production license from Coty in mid-2027 under a €4 billion deal with Kering. The company is encouraged by recent improvements in Gucci’s fashion and leather goods results and is tracking healthy e-commerce and luxury segment trends, while monitori…

Radware to Participate in Upcoming Investor Conferences

Radware to Participate in Upcoming Investor Conferences

Radware Ltd. (NASDAQ: RDWR), a leader in application security and delivery for multi-cloud environments, announced its management will participate in upcoming investor conferences including the Rosenblatt Technology Summit, Jefferies Semiconductor, IT & Communication Technology Conference, and Wolfe Research TMT Conference. The company emphasized i…

WTW Reports Second Quarter 2026 Earnings

WTW Reports Second Quarter 2026 Earnings

Willis Towers Watson (WTW) reported strong Q2 2026 results highlighted by a 9% increase in revenue to $2.47 billion and a 17% rise in adjusted diluted EPS to $3.35. The company launched Propel, an AI acceleration plan targeting around 30% adjusted operating margin by 2028 through scaling AI and automation. WTW also increased its share repurchase au…

Virtu Announces Second Quarter 2026 Results

Virtu Announces Second Quarter 2026 Results

Virtu Financial, Inc. announced its financial results for Q2 2026, exhibiting a 19% increase in total revenues to $1.19 billion and a 19.4% rise in normalized adjusted net income to $291.5 million compared to the same period in 2025. Despite a slight decrease in GAAP net income to $284.9 million, adjusted metrics and earnings per share showed signi…